These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24941805)

  • 21. Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.
    Ohmori H; Kamo M; Yamakoshi K; Nitta MH; Hikida M; Kanayama N
    Immunopharmacol Immunotoxicol; 2001 Feb; 23(1):75-82. PubMed ID: 11322651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.
    Moody TW
    Ann N Y Acad Sci; 2007 Sep; 1112():297-304. PubMed ID: 17567944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Tα1 on the infective patients after hematopoietic stem cell transplantation.
    Ding JH; Wang LL; Chen Z; Wang J; Yu ZP; Zhao G; Chen BA
    Int J Hematol; 2013 Feb; 97(2):280-3. PubMed ID: 23307511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a C-end rule modification on antitumor activity of thymosin α1.
    Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
    Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
    Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
    Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intein-mediated expression, purification, and characterization of thymosin α1-thymopentin fusion peptide in Escherichia coli.
    Li J; Zheng L; Li P; Wang F
    Protein Expr Purif; 2012 Jul; 84(1):1-8. PubMed ID: 22554820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.
    Jia Z; Feng Z; Tian R; Wang Q; Wang L
    Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of transcatheter arterial chemoembolization combined with thymosin alpha 1 on the autophagy of immune cells from advanced hepatocellular carcinoma].
    Fang SJ; Zheng LY; Zhao ZW; Fan XX; Xu M; Ji JS
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(25):1942-1946. PubMed ID: 28693071
    [No Abstract]   [Full Text] [Related]  

  • 31. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
    Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
    Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
    Romani L; Bistoni F; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Zelante T; Moretti S; Rasi G; Garaci E; Puccetti P
    Ann N Y Acad Sci; 2007 Sep; 1112():326-38. PubMed ID: 17495242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of thymosin alpha 1 combined with multi-modality chemotherapy and its effects on immune function of patients with pulmonary tuberculosis complicated with diabetes.
    Wu L; Luo PP; Tian YH; Chen LY; Zhang YL
    Pak J Med Sci; 2022; 38(1):179-184. PubMed ID: 35035422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of combined thymosin and hydrocortisone on immune response in septic mice.
    Zhang D; Zhou Y; Cheng Q
    Int J Clin Exp Med; 2015; 8(8):12989-94. PubMed ID: 26550219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymosin α1 and cancer: action on immune effector and tumor target cells.
    Garaci E; Pica F; Serafino A; Balestrieri E; Matteucci C; Moroni G; Sorrentino R; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P
    Ann N Y Acad Sci; 2012 Oct; 1269():26-33. PubMed ID: 23045967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists.
    Giacomini E; Severa M; Cruciani M; Etna MP; Rizzo F; Pardini M; Scagnolari C; Garaci E; Coccia EM
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S59-70. PubMed ID: 26096650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
    Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
    Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels.
    Qin Y; Chen FD; Zhou L; Gong XG; Han QF
    Chem Biol Interact; 2009 Aug; 180(3):383-8. PubMed ID: 19442654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.